BioMarin Pharmaceutical
Insider trading & Transactions

Last updated: 21 Feb 2019

Transaction	Date	Insider	Security	Shares	Price per share	Total value
Option	21 Feb 2019	BIENAIME JEAN JACQUES director, officer: Chief Executive O.. director, officer: Chief Execut..	Common Stock	3,000	$14.39	$43,170
Option	14 Feb 2019	BIENAIME JEAN JACQUES director, officer: Chief Executive O.. director, officer: Chief Execut..	Common Stock	4,000	$14.39	$57,560
Option	14 Feb 2019	BIENAIME JEAN JACQUES director, officer: Chief Executive O.. director, officer: Chief Execut..	Stock Option (Right to buy Common Stock)	4,000	$14.39	$57,560
Sale	14 Feb 2019	BIENAIME JEAN JACQUES director, officer: Chief Executive O.. director, officer: Chief Execut..	Common Stock	4,000	$14.39	$57,560
Sale	5 Feb 2019	BIENAIME JEAN JACQUES director, officer: Chief Executive O.. director, officer: Chief Execut..	Common Stock	4,000	$14.39	$57,560
Option	5 Feb 2019	BIENAIME JEAN JACQUES director, officer: Chief Executive O.. director, officer: Chief Execut..	Common Stock	4,000	$14.39	$57,560
Option	5 Feb 2019	BIENAIME JEAN JACQUES director, officer: Chief Executive O.. director, officer: Chief Execut..	Stock Option (Right to buy Common Stock)	4,000	$14.39	$57,560
Option	22 Jan 2019	BIENAIME JEAN JACQUES director, officer: Chief Executive O.. director, officer: Chief Execut..	Common Stock	3,000	$14.39	$43,170
Option	22 Jan 2019	BIENAIME JEAN JACQUES director, officer: Chief Executive O.. director, officer: Chief Execut..	Stock Option (Right to buy Common Stock)	3,000	$14.39	$43,170
Sale	22 Jan 2019	BIENAIME JEAN JACQUES director, officer: Chief Executive O.. director, officer: Chief Execut..	Common Stock	3,000	$14.39	$43,170
Sale	14 Jan 2019	BIENAIME JEAN JACQUES director, officer: Chief Executive O.. director, officer: Chief Execut..	Common Stock	4,000	$14.39	$57,560
Option	14 Jan 2019	BIENAIME JEAN JACQUES director, officer: Chief Executive O.. director, officer: Chief Execut..	Common Stock	4,000	$14.39	$57,560
Option	14 Jan 2019	BIENAIME JEAN JACQUES director, officer: Chief Executive O.. director, officer: Chief Execut..	Stock Option (Right to buy Common Stock)	4,000	$14.39	$57,560
Option	10 Jan 2019	BIENAIME JEAN JACQUES director, officer: Chief Executive O.. director, officer: Chief Execut..	Stock Option (Right to buy Common Stock)	3,000	$14.39	$43,170
Sale	10 Jan 2019	BIENAIME JEAN JACQUES director, officer: Chief Executive O.. director, officer: Chief Execut..	Common Stock	3,000	$14.39	$43,170
Option	10 Jan 2019	BIENAIME JEAN JACQUES director, officer: Chief Executive O.. director, officer: Chief Execut..	Common Stock	3,000	$14.39	$43,170
Option	8 Jan 2019	BIENAIME JEAN JACQUES director, officer: Chief Executive O.. director, officer: Chief Execut..	Stock Option (Right to buy Common Stock)	6,000	$14.39	$86,340
Sale	8 Jan 2019	BIENAIME JEAN JACQUES director, officer: Chief Executive O.. director, officer: Chief Execut..	Common Stock	6,000	$91.48	$548,856
Option	8 Jan 2019	BIENAIME JEAN JACQUES director, officer: Chief Executive O.. director, officer: Chief Execut..	Common Stock	6,000	$14.39	$86,340
Option	7 Jan 2019	BIENAIME JEAN JACQUES director, officer: Chief Executive O.. director, officer: Chief Execut..	Stock Option (Right to buy Common Stock)	3,000	$14.39	$43,170
Sale	7 Jan 2019	BIENAIME JEAN JACQUES director, officer: Chief Executive O.. director, officer: Chief Execut..	Common Stock	3,000	$14.39	$43,170
Option	7 Jan 2019	BIENAIME JEAN JACQUES director, officer: Chief Executive O.. director, officer: Chief Execut..	Common Stock	3,000	$14.39	$43,170
Option	28 Dec 2018	BIENAIME JEAN JACQUES director, officer: Chief Executive O.. director, officer: Chief Execut..	Stock Option (Right to buy Common Stock)	3,000	$14.39	$43,170
Sale	28 Dec 2018	BIENAIME JEAN JACQUES director, officer: Chief Executive O.. director, officer: Chief Execut..	Common Stock	3,000	$14.39	$43,170
Option	28 Dec 2018	BIENAIME JEAN JACQUES director, officer: Chief Executive O.. director, officer: Chief Execut..	Common Stock	3,000	$14.39	$43,170
Option	27 Dec 2018	LAWLIS V BRYAN director director	Stock Option (Right to buy Common Stock)	2,150	$14.39	$30,939
Sale	27 Dec 2018	LAWLIS V BRYAN director director	Common Stock	2,150	$14.39	$30,939
Option	27 Dec 2018	LAWLIS V BRYAN director director	Common Stock	2,150	$14.39	$30,939
Option	26 Dec 2018	BIENAIME JEAN JACQUES director, officer: Chief Executive O.. director, officer: Chief Execut..	Common Stock	4,000	$14.39	$57,560
Option	26 Dec 2018	BIENAIME JEAN JACQUES director, officer: Chief Executive O.. director, officer: Chief Execut..	Stock Option (Right to buy Common Stock)	4,000	$14.39	$57,560
Sale	26 Dec 2018	BIENAIME JEAN JACQUES director, officer: Chief Executive O.. director, officer: Chief Execut..	Common Stock	4,000	$14.39	$57,560
Option	14 Dec 2018	BIENAIME JEAN JACQUES director, officer: Chief Executive O.. director, officer: Chief Execut..	Stock Option (Right to buy Common Stock)	2,000	$17.86	$35,720
Sale	14 Dec 2018	BIENAIME JEAN JACQUES director, officer: Chief Executive O.. director, officer: Chief Execut..	Common Stock	2,000	$17.86	$35,720
Option	14 Dec 2018	BIENAIME JEAN JACQUES director, officer: Chief Executive O.. director, officer: Chief Execut..	Common Stock	2,000	$17.86	$35,720
Option	12 Dec 2018	BIENAIME JEAN JACQUES director, officer: Chief Executive O.. director, officer: Chief Execut..	Common Stock	2,000	$17.86	$35,720
Option	12 Dec 2018	BIENAIME JEAN JACQUES director, officer: Chief Executive O.. director, officer: Chief Execut..	Stock Option (Right to buy Common Stock)	2,000	$17.86	$35,720
Sale	12 Dec 2018	BIENAIME JEAN JACQUES director, officer: Chief Executive O.. director, officer: Chief Execut..	Common Stock	2,000	$17.86	$35,720
Sale	14 Nov 2018	AJER JEFFREY ROBERT officer: EVP, Chief Commercial Officer officer: EVP, Chief Commercial ..	Common Stock	9,000	$93	$836,973
Option	14 Nov 2018	AJER JEFFREY ROBERT officer: EVP, Chief Commercial Officer officer: EVP, Chief Commercial ..	Common Stock	9,000	$63.1	$567,900
Option	14 Nov 2018	AJER JEFFREY ROBERT officer: EVP, Chief Commercial Officer officer: EVP, Chief Commercial ..	Stock Option (Right to buy Common Stock)	9,000	$63.1	$567,900
Option	2 Nov 2018	BIENAIME JEAN JACQUES director, officer: Chief Executive O.. director, officer: Chief Execut..	Stock Option (Right to buy Common Stock)	1,500	$17.86	$26,790
Sale	2 Nov 2018	BIENAIME JEAN JACQUES director, officer: Chief Executive O.. director, officer: Chief Execut..	Common Stock	1,500	$17.86	$26,790
Option	2 Nov 2018	BIENAIME JEAN JACQUES director, officer: Chief Executive O.. director, officer: Chief Execut..	Common Stock	1,500	$17.86	$26,790
Option	1 Nov 2018	BIENAIME JEAN JACQUES director, officer: Chief Executive O.. director, officer: Chief Execut..	Stock Option (Right to buy Common Stock)	4,000	$14.39	$57,560
Sale	1 Nov 2018	BIENAIME JEAN JACQUES director, officer: Chief Executive O.. director, officer: Chief Execut..	Common Stock	4,000	$14.39	$57,560
Option	1 Nov 2018	BIENAIME JEAN JACQUES director, officer: Chief Executive O.. director, officer: Chief Execut..	Common Stock	4,000	$14.39	$57,560
Option	30 Oct 2018	BIENAIME JEAN JACQUES director, officer: Chief Executive O.. director, officer: Chief Execut..	Stock Option (Right to buy Common Stock)	1,000	$14.39	$14,390
Option	30 Oct 2018	BIENAIME JEAN JACQUES director, officer: Chief Executive O.. director, officer: Chief Execut..	Common Stock	1,000	$14.39	$14,390
Option	24 Oct 2018	BIENAIME JEAN JACQUES director, officer: Chief Executive O.. director, officer: Chief Execut..	Stock Option (Right to buy Common Stock)	1,000	$14.39	$14,390
Option	24 Oct 2018	BIENAIME JEAN JACQUES director, officer: Chief Executive O.. director, officer: Chief Execut..	Common Stock	1,000	$14.39	$14,390

Showing 450 to 500 of 2449 results.

Insider trading

Monitoring trades made by the management members or major shareholders of companies may help create a sharper picture of what is happening inside the companies. Base your decisions on buys or sells of the people involved and do the right thing at the right time.

Who is insider?

Every director or senior officer, as well as any other entity or individual owning more than 10% of the company’s shares on the stock market, is called an insider. Such people or entities are allowed to buy/sell the company's shares under strictly controlled conditions. Key premise here is that none of them can make trades based on non-public information about the company.

BioMarin Pharmaceutical Insider trading & Transactions

Insider trading

Who is insider?

Similar companies insider trading:

BioMarin Pharmaceutical
Insider trading & Transactions